Pep2Tango Therapeutics, a Potomac, MD-based startup focused on weight loss therapies, received an investment from Versant Ventures. The amount of the deal was not disclosed. The company intends to use the funds to develop its novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. Led by President, CEO and Chairperson Cristina Rondinone, Ph.D., and CSO Soumitra Ghosh, Ph.D., Pep2Tango Therapeutics is a biotech…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.